June 29, 2021
Open to all ISPOR Members and Non-members
Moderated by: Joseph Monforte
Presented by:
- Sreeram Ramagopalan
- Sara Bruce Wirta
- Aliki Taylor
- Yan Xiao
June 29, 2021
11:00AM EDT | 4:00PM BST | 5:00PM CEST
Click here for time zone conversion
Join us for what promises to be an interesting thoughtful discussion regarding this fast-growing opportunity for market development and clinical impact.
Learning Objectives:
- Understanding the unique attributes of oncology care in China- the challenges and opportunities for RWE and outcomes researchers.
- Ways to effectively manage Chinese data and privacy regulations to support global pharma RWE research and market access teams.
Register Here
Sponsored by: GenomiCare Biotechnology
Presenters:
Joseph Monforte, PhD, Head of Strategic Partnering, GenomiCare Biotechnology
Sreeram Ramagopalan, PhD, Global Head Real-World Evidence, Roche, Basel, Switzerland
Sara Bruce Wirta, PhD, Director RWE & Data Science, Innovation & Partnerships, Novartis, Stockholm, Sweden
Aliki Taylor, PhD, MPH Senior Director Global Medical Evidence Generation, AstraZeneca, Cambridge, United Kingdom
Yan Xiao, RWD / Senior Director, AstraZeneca R&D China, Beijing, China
Reservations are on a first-come, first-served basis.